Takeda Pharmaceutical Co. Ltd. - Enterprise Value To Sales Ratio

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.

The item "Enterprise-Value-To-Sales-Ratio" stands at 2.41 as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Enterprise Value To Sales Ratio" stands at 2.41. This represents a decrease of -0.72 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 4.73 percent compared to the value the year prior.
The 1 year change in percent is 4.73.
The 3 year change in percent is -1.33.

The Serie's long term average value is 2.45. It's latest available value, on 09/30/2025, is 1.47 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2024, to it's latest available value, on 09/30/2025, is +4.73%.
The Serie's change in percent from it's maximum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is -9.33%.